Source: FinanzNachrichten

Gilead: Gilead Sciences: The Global Health Challenge of HIV and Hepatitis B Coinfections

NORTHAMPTON, MA / ACCESS Newswire / April 8, 2025 / In 2019, Somchai, a Thai native, was 21 years old and faced a double threat to his long-term health and wellbeing. He was living with hepatitis B...

Read full article »
Annual Revenue
$10-50B
Employees
10-50K
Daniel O’Day's photo - Chairman & CEO of Gilead

Chairman & CEO

Daniel O’Day

CEO Approval Rating

66/100

Read more